NEW YORK, Nov. 03, 2016 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Adeptus Health Inc. (“Adeptus” or the “Company”) (NYSE:ADPT) and certain of its officers. This case is on behalf of shareholders who purchased or otherwise acquired shares pursuant and/or traceable to the Company’s secondary public offering (the “SPO”) on or about July 31, 2015, or purchasers of common shares between April 23, 2015 and November 16, 2015, inclusive (the “Class Period”).
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose: (1) that Adeptus engaged in an extensive predatory billing practice, predominantly in connection with lower acuity level patients; (2) that the Company’s predatory billing practices subjected the Company to several known and undisclosed risks, including financial risks, reputational risks, risks associated with improper financial reporting, civil or criminal sanctions, and exclusion from federal and state healthcare programs; (3) that Adeptus’ financial statements were inadequate with Generally Accepted Accounting Principles; (4) contrary to Adeptus’ statements about its practice of referring lower acuity patients to urgent care facilities, Adeptus regularly treated lower acuity patients and unreasonably billed for services; (5) consequently, Adeptus lacked a reasonable basis for its statements about its business and future financial prospects at all relevant times.
On November 17, 2015, a television station aired an investigative report about Adeptus Health’s predatory billing practices at Colorado First Choice emergency rooms. Once this information was made public, Adeptus stock dropped in value.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/adpt or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [email protected]. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Adeptus you have until December 27, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 



